SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001815776-24-000053
Filing Date
2024-08-12
Accepted
2024-08-12 08:05:27
Documents
15
Period of Report
2024-08-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lenz-20240812.htm   iXBRL 8-K 29697
2 EX-99.1 exhibit991-nda8xk.htm EX-99.1 8875
6 image.jpg GRAPHIC 1629
  Complete submission text file 0001815776-24-000053.txt   173815

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lenz-20240812.xsd EX-101.SCH 1889
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lenz-20240812_lab.xml EX-101.LAB 23433
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lenz-20240812_pre.xml EX-101.PRE 13570
18 EXTRACTED XBRL INSTANCE DOCUMENT lenz-20240812_htm.xml XML 3041
Mailing Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014
Business Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 241194794
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)